Core Viewpoint - The Shanghai Stock Exchange has decided to terminate the review of Guizhou Zhongyida Co., Ltd.'s application for a specific issuance of shares, following the company's decision to withdraw its application due to ongoing high debt levels and financial instability [2][2][2] Group 1: Company Actions - On November 7, 2025, the company held board meetings to approve the proposal to terminate the issuance of A-shares to specific investors [2] - On November 11, 2025, the company and its sponsors submitted withdrawal applications to the Shanghai Stock Exchange [2] - The company originally planned to issue up to 68.4039 million shares, raising a total of no more than 210 million yuan, intended for working capital and debt repayment [2][2] Group 2: Financial Health - The company's debt-to-asset ratios for the years 2021 to 2024 were reported at 90.32%, 88.89%, 97.88%, and 93.47%, with a ratio of 89.08% reported at the end of Q3 2025 [2] - The consistently high debt levels indicate significant repayment pressure and potential financial instability for the company [2][2] Group 3: Market Reaction - On November 12, 2025, the company's stock price fell by 5.07%, closing at 12.17 yuan per share [2] - Earlier in 2025, the company's stock price surged from 3.78 yuan per share to a peak of 18.96 yuan per share due to rising prices of its main product, pentaerythritol [2][2]
中毅达:上交所决定终止定增审核 公司资产负债率居高不下